Literature DB >> 22146897

[Surgical management of Pyoderma gangrenosum].

I Sick1, B Trautner, T Ruzicka.   

Abstract

Pyoderma gangrenosum is a rare affection of unknown etiology, which is often associated with systemic diseases such as chronic inflammatory bowel disease, hematologic disorders, carcinomas and arthritis. Treatment may include topical corticosteroids or calcineurin inhibitors in combination with systemic corticosteroids, cyclosporine A, azathioprine, cyclophosphamide, mycophenolate mofetil, intravenous immunoglobulins or monoclonal antibodies against TNFα but all these approaches are off-label. Surgical therapy is difficult because of pathergy. Nevertheless, after having stopped the inflammation, the ulcers can be treated by split thickness skin grafts and simultaneous immunosuppression. We present three cases with successful surgical treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22146897     DOI: 10.1007/s00105-011-2269-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  27 in total

1.  [Prevention of pyoderma gangrenosum].

Authors:  A Geusau
Journal:  Hautarzt       Date:  2000-03       Impact factor: 0.751

2.  Pyoderma gangrenosum following surgical procedures.

Authors:  Nobuyuki Kikuchi; Yuka Hanami; Takako Miura; Yoshio Kawakami; Masataka Satoh; Mikio Ohtsuka; Toshiyuki Yamamoto
Journal:  Int J Dermatol       Date:  2010-03       Impact factor: 2.736

3.  Successful grafting with EpiDex in pyoderma gangrenosum.

Authors:  Jürg Hafner; Andreas Kühne; Ralph M Trüeb
Journal:  Dermatology       Date:  2006       Impact factor: 5.366

4.  Pyoderma gangraenosum as a complication to knee arthroscopy.

Authors:  Jakob Torp Madsen; Ole Skov; Klaus E Andersen
Journal:  Knee       Date:  2009-01-20       Impact factor: 2.199

5.  A pyoderma gangrenosum following breast reconstruction: a rare cause of skin necrosis.

Authors:  Mario Rietjens; Giuseppe Cuccia; Fabricio Brenelli; Andrea Manconi; Stefano Martella; Francesca De Lorenzi
Journal:  Breast J       Date:  2009-12-29       Impact factor: 2.431

6.  Aberrant integrin (CR4; alpha(x)beta2; CD11c/CD18) oscillations on neutrophils in a mild form of pyoderma gangrenosum.

Authors:  S Shaya; A L Kindzelskii; J Minor; E C Moore; R F Todd; H R Petty
Journal:  J Invest Dermatol       Date:  1998-07       Impact factor: 8.551

Review 7.  Medical and surgical management of paraneoplastic pyoderma gangrenosum--a case report and review of the literature.

Authors:  S Lamet; A Bracke; E Geluykens; E Vlieghe; K Seymons; A P Gadisseur; I Vrelust; V Van Marck; J Somville; J Lambert
Journal:  Acta Clin Belg       Date:  2010 Jan-Feb       Impact factor: 1.264

Review 8.  Minimizing the risk of post-operative pyoderma gangrenosum.

Authors:  C C Long; J Jessop; M Young; P J Holt
Journal:  Br J Dermatol       Date:  1992-07       Impact factor: 9.302

9.  Management of an unfortunate triad after breast reconstruction: pyoderma gangrenosum, full-thickness chest wall defect and Acinetobacter Baumannii Infection.

Authors:  Michael V Schintler; Martin Grohmann; Claudio Donia; Elisabeth Aberer; Erwin Scharnagl
Journal:  J Plast Reconstr Aesthet Surg       Date:  2010-02-11       Impact factor: 2.740

10.  Pyoderma gangranosum of the penis.

Authors:  Tae Heung Kim; Seung Young Oh; Soon Chul Myung
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

View more
  2 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

Review 2.  Pyoderma gangrenosum: challenges and solutions.

Authors:  Ana Gameiro; Neide Pereira; José Carlos Cardoso; Margarida Gonçalo
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-05-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.